Login
Toggle sidebar

Lint: primary-urethral-cancer-staging-1

primary-urethral-cancer-staging-1
Strong List Colon Position
error

"Tx: primary tumour cannot be assessed"

Line 5:8 · When enboldening an intro, the colon should not be bold. '<strong>Tx:</strong> primary'

"T0: no evidence of primary tumour"

Line 6:8 · When enboldening an intro, the colon should not be bold. '<strong>T0:</strong> no'

"Tis: carcinoma in situ"

Line 7:8 · When enboldening an intro, the colon should not be bold. '<strong>Tis:</strong> carcinoma'

"Ta: non-invasive papillary, polypoid, or verrucous carcinoma"

Line 8:8 · When enboldening an intro, the colon should not be bold. '<strong>Ta:</strong> non'

"T1: invasion of subepithelial connective tissue"

Line 9:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> invasion'

"T2: invasion of corpus spongiosum/prostate or peri urethral muscles"

Line 10:8 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> invasion'

"T3: corpus cavernosum, beyond prostate capsule, anterior vagina, bladder neck"

Line 11:8 · When enboldening an intro, the colon should not be bold. '<strong>T3:</strong> corpus'

"T4: invasion of adjacent organs"

Line 12:8 · When enboldening an intro, the colon should not be bold. '<strong>T4:</strong> invasion'

"Tx: primary tumour cannot be assessed"

Line 16:8 · When enboldening an intro, the colon should not be bold. '<strong>Tx:</strong> primary'

"T0: no evidence of primary tumour"

Line 17:8 · When enboldening an intro, the colon should not be bold. '<strong>T0:</strong> no'

"Tis: carcinoma in situ"

Line 18:8 · When enboldening an intro, the colon should not be bold. '<strong>Tis:</strong> carcinoma'

"Tis pu: carcinoma in situ with involvement of prostatic urethra"

Line 19:8 · When enboldening an intro, the colon should not be bold. '<strong>Tis pu:</strong> carcinoma'

"Tis pd: carcinoma in situ with involvement of prostatic ducts"

Line 20:8 · When enboldening an intro, the colon should not be bold. '<strong>Tis pd:</strong> carcinoma'

"Ta: non-invasive papillary, polypoid, or verrucous carcinoma"

Line 21:8 · When enboldening an intro, the colon should not be bold. '<strong>Ta:</strong> non'

"T1: invasion of subepithelial connective tissue"

Line 22:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> invasion'

"T2: invasion of corpus spongiosum/prostate or periurethral muscles"

Line 23:8 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> invasion'

"T3: corpus cavernosum, beyond prostate capsule, anterior vagina, bladder neck"

Line 24:8 · When enboldening an intro, the colon should not be bold. '<strong>T3:</strong> corpus'

"T4: invasion of adjacent organs"

Line 25:8 · When enboldening an intro, the colon should not be bold. '<strong>T4:</strong> invasion'

"Nx: nodal status cannot be assessed"

Line 29:8 · When enboldening an intro, the colon should not be bold. '<strong>Nx:</strong> nodal'

"N0: no nodal involvement"

Line 30:8 · When enboldening an intro, the colon should not be bold. '<strong>N0:</strong> no'

"N1: single nodal metastasis"

Line 31:8 · When enboldening an intro, the colon should not be bold. '<strong>N1:</strong> single'

"N2: single node more than 2 cm in greatest dimension or multiple nodes"

Line 32:8 · When enboldening an intro, the colon should not be bold. '<strong>N2:</strong> single'

"Mx: distant metastatic disease cannot be assessed"

Line 36:8 · When enboldening an intro, the colon should not be bold. '<strong>Mx:</strong> distant'

"M0: no distant metastases"

Line 37:8 · When enboldening an intro, the colon should not be bold. '<strong>M0:</strong> no'

"M1: distant metastases present"

Line 38:8 · When enboldening an intro, the colon should not be bold. '<strong>M1:</strong> distant'
Acronyms
warning

"Primary urethral cancer staging often uses the TNM system and is as follows:"

Line 1:68 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.

"TNM staging"

Line 2:5 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Case
warning

"Primary tumour staging (T)"

Line 3:5 · 'Primary tumour staging (T)' should use sentence-style capitalization.

"​Nodal status (N)"

Line 27:5 · '​Nodal status (N)' should use sentence-style capitalization.

"Metastases (M)"

Line 34:5 · 'Metastases (M)' should use sentence-style capitalization.
List Caps
warning

"Tx: primary tumour cannot be assessed"

Line 5:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis: carcinoma in situ"

Line 7:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Ta: non-invasive papillary, polypoid, or verrucous carcinoma"

Line 8:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tx: primary tumour cannot be assessed"

Line 16:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis: carcinoma in situ"

Line 18:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis pu: carcinoma in situ with involvement of prostatic urethra"

Line 19:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis pd: carcinoma in situ with involvement of prostatic ducts"

Line 20:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Ta: non-invasive papillary, polypoid, or verrucous carcinoma"

Line 21:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Nx: nodal status cannot be assessed"

Line 29:16 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis pu, N0, M0"

Line 50:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Tis pd, N0, M0"

Line 51:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Strong
warning

"For urothelial carcinoma"

Line 14:4 · Generally, don't use bold in text: '<strong>For urothelial carcinoma</strong>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"TNM staging"

Line 2:1 · "TNM staging" is not a recognised heading for this article type.

"Primary tumour staging (T)"

Line 3:1 · "Primary tumour staging (T)" is not a recognised heading for this article type.

"​Nodal status (N)"

Line 27:1 · "​Nodal status (N)" is not a recognised heading for this article type.

"Metastases (M)"

Line 34:1 · "Metastases (M)" is not a recognised heading for this article type.

"Stage groupings"

Line 40:1 · "Stage groupings" is not a recognised heading for this article type.
Links